The surge in semaglutide prescriptions for type 2 diabetes and obesity management has brought a rare but serious side effect into clinical focus. Recent research published in JAMA Ophthalmology highlights a potential association between Ozempic and Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION), commonly referred to as an eye stroke.